IBDEI2BV ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,39476,2)
 ;;=^5002632
 ;;^UTILITY(U,$J,358.3,39477,0)
 ;;=E10.9^^153^1925^13
 ;;^UTILITY(U,$J,358.3,39477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39477,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,39477,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,39477,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,39478,0)
 ;;=E10.311^^153^1925^11
 ;;^UTILITY(U,$J,358.3,39478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39478,1,3,0)
 ;;=3^DM Type 1 w/ Unspec Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,39478,1,4,0)
 ;;=4^E10.311
 ;;^UTILITY(U,$J,358.3,39478,2)
 ;;=^5002592
 ;;^UTILITY(U,$J,358.3,39479,0)
 ;;=E10.319^^153^1925^12
 ;;^UTILITY(U,$J,358.3,39479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39479,1,3,0)
 ;;=3^DM Type 1 w/ Unspec Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,39479,1,4,0)
 ;;=4^E10.319
 ;;^UTILITY(U,$J,358.3,39479,2)
 ;;=^5002593
 ;;^UTILITY(U,$J,358.3,39480,0)
 ;;=E10.36^^153^1925^1
 ;;^UTILITY(U,$J,358.3,39480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39480,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Cataract
 ;;^UTILITY(U,$J,358.3,39480,1,4,0)
 ;;=4^E10.36
 ;;^UTILITY(U,$J,358.3,39480,2)
 ;;=^5002602
 ;;^UTILITY(U,$J,358.3,39481,0)
 ;;=E10.39^^153^1925^2
 ;;^UTILITY(U,$J,358.3,39481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39481,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Ophthalmic Complication
 ;;^UTILITY(U,$J,358.3,39481,1,4,0)
 ;;=4^E10.39
 ;;^UTILITY(U,$J,358.3,39481,2)
 ;;=^5002603
 ;;^UTILITY(U,$J,358.3,39482,0)
 ;;=E10.321^^153^1925^3
 ;;^UTILITY(U,$J,358.3,39482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39482,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,39482,1,4,0)
 ;;=4^E10.321
 ;;^UTILITY(U,$J,358.3,39482,2)
 ;;=^5002594
 ;;^UTILITY(U,$J,358.3,39483,0)
 ;;=E10.329^^153^1925^4
 ;;^UTILITY(U,$J,358.3,39483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39483,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,39483,1,4,0)
 ;;=4^E10.329
 ;;^UTILITY(U,$J,358.3,39483,2)
 ;;=^5002595
 ;;^UTILITY(U,$J,358.3,39484,0)
 ;;=E10.331^^153^1925^5
 ;;^UTILITY(U,$J,358.3,39484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39484,1,3,0)
 ;;=3^DM Type 1 w/ Moderate Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,39484,1,4,0)
 ;;=4^E10.331
 ;;^UTILITY(U,$J,358.3,39484,2)
 ;;=^5002596
 ;;^UTILITY(U,$J,358.3,39485,0)
 ;;=E10.339^^153^1925^6
 ;;^UTILITY(U,$J,358.3,39485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39485,1,3,0)
 ;;=3^DM Type 1 w/ Moderate Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,39485,1,4,0)
 ;;=4^E10.339
 ;;^UTILITY(U,$J,358.3,39485,2)
 ;;=^5002597
 ;;^UTILITY(U,$J,358.3,39486,0)
 ;;=E10.341^^153^1925^9
 ;;^UTILITY(U,$J,358.3,39486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39486,1,3,0)
 ;;=3^DM Type 1 w/ Severe Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,39486,1,4,0)
 ;;=4^E10.341
 ;;^UTILITY(U,$J,358.3,39486,2)
 ;;=^5002598
 ;;^UTILITY(U,$J,358.3,39487,0)
 ;;=E10.349^^153^1925^10
 ;;^UTILITY(U,$J,358.3,39487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39487,1,3,0)
 ;;=3^DM Type 1 w/ Severe Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,39487,1,4,0)
 ;;=4^E10.349
 ;;^UTILITY(U,$J,358.3,39487,2)
 ;;=^5002599
 ;;^UTILITY(U,$J,358.3,39488,0)
 ;;=E10.351^^153^1925^7
 ;;^UTILITY(U,$J,358.3,39488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39488,1,3,0)
 ;;=3^DM Type 1 w/ Prolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,39488,1,4,0)
 ;;=4^E10.351
